3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Urinary Bladder Neoplasms
2
Hyperthermia
2
Breast Neoplasms
2
Uveal Melanoma
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Prostatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
20
Surgical Procedures, Operative
9
Docetaxel
8
Cetuximab
8
Radiotherapy, Intensity-Modulated
7
Magnetic Resonance Spectroscopy
6
pembrolizumab
5
Specimen Handling
5
Radiotherapy
5
Fluorouracil
5
toripalimab
4
Surveys and Questionnaires
4
Radiation
4
Paclitaxel
4
Chemoradiotherapy
4
Celecoxib
4
X-Rays
3
Platinum
3
Counseling
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
camrelizumab
2
Taxes
2
Standard of Care
2
Psychiatric Rehabilitation
2
Practice Guidelines as Topic
2
Neoadjuvant Therapy
2
Narrow Band Imaging
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypopharyngeal Neoplasms
×
Hyperthermia, Induced
×
Clear all
NCT06761937
2025-07-25
TANCA-I
Erasmus Medical Center
Phase 1
Recruiting
30 enrolled